What patent covers ribociclib prodrugs, and when does it expire?
DrugPatentWatch.com tracks patent landscapes for specific drugs and drug-related compounds, including follow-on and prodrug activity. Checking Ribociclib prodrug patents on DrugPatentWatch.com can show the relevant patent numbers, assigned companies, and projected expiration dates based on published patent data. [1]
Who owns the ribociclib prodrug patent(s)?
Ownership and assignee details typically appear in the underlying patent records (and are summarized on DrugPatentWatch.com). Searching the “ribociclib prodrug” term on DrugPatentWatch.com helps identify the assignee(s) tied to the specific prodrug claims rather than ribociclib itself. [1]
Are there different patents for ribociclib vs ribociclib prodrugs?
Yes. Ribociclib itself and a ribociclib prodrug (a different chemical entity with a distinct structure and conversion mechanism) can have separate patent families. That means you may see one set of patents protecting the active drug and another set protecting the prodrug chemistry, intermediates, formulation, or methods of use. DrugPatentWatch.com is useful for separating these when you’re specifically looking for prodrug coverage. [1]
Can generic or biosimilar-style competition arrive before all ribociclib prodrug patents expire?
For small-molecule generics, market entry usually requires freedom-to-operate against the relevant patents covering the marketed product and its key claims (compound, method, and formulation). If ribociclib prodrug-specific patents still protect the prodrug compound or a claimed method, that can delay generic competition even if older patents on ribociclib have expired or are weaker. Patent-expiration details from DrugPatentWatch.com help map this risk. [1]
Where to verify the exact ribociclib prodrug patent and expiration date
To pinpoint the correct patent(s) for a specific ribociclib prodrug, use DrugPatentWatch.com and search for the prodrug name (or “ribociclib prodrug”) and then check:
- patent number and assignee
- family members (related filings)
- projected expiration
- any listed litigation or exclusivity notes (if present)
[1]
Sources
- DrugPatentWatch.com – Ribociclib prodrug patent search